BridgeMD
Compares treatment options for Distal Radius Fracture
Official title No Reduction Compared to Closed Reduction for Distal Radius Fractures in Patients Over 65 or Older
ClinicalTrials.gov ID: NCT07042139
What this study is testing
- What it's testing
- DISCLOSE trial is a randomized controlled trial including 532 participants with low-energy distal radius fractures. The primary objective is to evaluate whether casting without prior closed reduction is equivalent to casting following closed reduction with respect to wrist-related pain and disability, as measured by the Patient-Rated Wrist Evaluation (PRWE) score at 12 months, in patients aged 65 years or older with a displaced distal radius fracture.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 65 and older
You may be able to join if
- Age 65 years or older
- Independent living patients
- Displaced distal radius fracture (AO/OTA 23A/23C) with 15-40 degree dorsal angulation, and/or of shortening of the radius for more than 2 mm.
- Associated ulnar styloid fracture is permitted
- Low energy injury, (fall from \<1 m)
You likely can't join if
- Patient unable to provide consent
- Patients who are actively working in a paid position
- Volar angulation, partial articular fractures (AO/OTA 23B)
- Concomitant fracture of the ulna proximal to the base of the styloid process
- Associated fracture or dislocation in any other body part that would affect the use of the injured distal radius
- Distal radius fractures in both arms
See the full eligibility criteria
- Age 65 years or older
- Independent living patients
- Displaced distal radius fracture (AO/OTA 23A/23C) with 15-40 degree dorsal angulation, and/or of shortening of the radius for more than 2 mm.
- Associated ulnar styloid fracture is permitted
- Low energy injury, (fall from \<1 m)
- Patient unable to provide consent
- Patients who are actively working in a paid position
- Volar angulation, partial articular fractures (AO/OTA 23B)
- Concomitant fracture of the ulna proximal to the base of the styloid process
- Associated fracture or dislocation in any other body part that would affect the use of the injured distal radius
- Distal radius fractures in both arms
- Open injury, Gustilo 2 or higher
- No bony contact between the main fragments
- High energy injuries
The study team makes the final eligibility decision.
Where it's taking place
- Viborg, Denmark
- Tartu, Estonia
- Tampere, Pirkanmaa, Finland
- Helsinki, Uusimaa, Finland
- Hämeenlinna, Finland
- Kuopio, Finland
- Oulu, Finland
- Pori, Finland
- Turku, Finland
- Stockholm, Sweden
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 65 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Viborg, Denmark; Tartu, Estonia; Tampere, Pirkanmaa, Finland; Helsinki, Uusimaa, Finland; Hämeenlinna, Finland; Kuopio, Finland and 4 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.